CCM
TMO icon

Catapult Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Catapult Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-50,000
Closed -$6.49M – 229
2015
Q2 		$6.49M Buy
+50,000
New +$6.52M 0.93% 19
2014
Q1 		– Sell
-6,471
Closed -$721K – 268
2013
Q4 		$721K Buy
+6,471
New +$643K 0.17% 125

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Catapult Capital Management's TMO Position: Q3 2015 in Review

Catapult Capital Management sold out of Thermo Fisher Scientific (TMO) in Q3 2015, closing a stake of 50,000 shares — an estimated $6.49M sold.

Catapult Capital Management first reported a position in TMO in Q4 2013 and held it in 2 quarters. The position peaked at $6.49M in Q2 2015. 971 funds tracked by Wall St. Rank hold TMO as of Q3 2015.

  • Catapult Capital Management reported no remaining Thermo Fisher Scientific position as of Q3 2015 after selling out during the quarter.
  • Catapult Capital Management sold 50,000 Thermo Fisher Scientific shares in Q3 2015, an estimated $6.49M.
  • Catapult Capital Management first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 2 quarters.
  • Catapult Capital Management's Thermo Fisher Scientific position peaked at $6.49M in Q2 2015.
  • 971 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.